Sputnik V uses viral vector technology. In this type of vaccine, another virus (in this case, the adenovirus) “takes” the genetic material of the coronavirus, the RNA, into our body.

The Russian Ministry of Health registered the nasal version of the COVID-19 vaccine Sputnik V, developed by the Gamaleya Institute of that country. The injectable immunizer was the first to be ...

According to the statement, Sputnik V demonstrated significantly less of a reduction in its virus neutralizing activity against a number of variants compared to data from other vaccine producers ...

Sputnik V was the first covid -19 vaccine registered in the world with “the heterogeneous booster approach,” using human adenovirus serotype 26 as the first component and serotype 5 as the ...

Clinical trials of the combination of the AZD1222 vaccine with the Sputnik V human adenoviral serotype Ad26 vector will be launched soon. The R-Pharm company will also be one of the sponsors of ...

An inhalable version of a single-shot, adenovirus-based viral vector vaccine might provide a new option for COVID-19 vaccination. In October 2021, the World Health Organization set a target for ...

There are 2 billion people who have received inactivated Chinese vaccines in the country and globally. As China has just authorized mix & match boosting with domestic vaccines, the Russian one ...

A man is injected with Sputnik-V vaccine against the coronavirus disease in Ukraine on February 3, 2021. The vaccine is soon going to be available in Kenya through a private pharmacy. [Reuters ...